Atlas Trials

Subcutaneous Versus Intravenous Morphine When Switching From Oral to Parenteral Route in Palliative Cancer Patients

Clinical trial NCT05236647 · COMPLETED

Trial details

NCT number
NCT05236647
Sponsor
University Hospital, Akershus
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pain Cancer
Start date
2022-03-08
Primary completion
2025-01-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.